Huda Zoghbi is a Howard Hughes Medical Institute investigator and professor of molecular and human genetics at Baylor College of Medicine in Houston, Texas. She is also director of the Jan and Dan Duncan Neurological Research Institute. Zoghbi explores the biology of genetic disorders such as Rett syndrome, and the genes essential for normal neurodevelopment.
Huda Zoghbi
Professor
Baylor College of Medicine
From this contributor
Remembering Steve Warren (1953-2021): A giant in the field of genetics
Steve Warren co-discovered the genetic mechanism that underpins fragile X syndrome and was a generous, inspiring mentor to many.
Remembering Steve Warren (1953-2021): A giant in the field of genetics
By
Joseph Cubells, Evan Eichler, James Sutcliffe, Huda Zoghbi
6 September 2021 | 11 min read
Questions for Huda Zoghbi: Studying Rett in the rodent brain
Removing the Rett syndrome gene, MeCP2, from distinct cells and brain regions reveals hidden features of the condition.
Questions for Huda Zoghbi: Studying Rett in the rodent brain
By
Jessica Wright
14 March 2017 | 6 min read
Explore more from The Transmitter
Cell population in brainstem coordinates cough, new study shows
The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.
Cell population in brainstem coordinates cough, new study shows
The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.
By
Calli McMurray
6 September 2024 | 5 min read
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
The current Autism CARES Act sunsets in late September.
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
The current Autism CARES Act sunsets in late September.
By
Rachel Zamzow
5 September 2024 | 5 min listen
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.
By
Olivia Gieger
4 September 2024 | 6 min read